NEW YORK--(BUSINESS WIRE)--Accenture (NYSE: ACN) and Bristol-Myers Squibb Company (NYSE: BMY) today launched in Chennai, India, the pharmaceutical industry’s first joint center for pharmacovigilance. Pharmacovigilance is the monitoring of safety data to ensure optimal use of medicines. It entails the capture, assessment, and reporting of potential side effects to medicines.
